BBHC
PRCT icon

Brown Brothers Harriman & Co’s Procept Biorobotics PRCT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,869
Closed -$702K – 1289
2023
Q2 		$702K Buy
+19,869
New +$657K 0.01% 290

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Brothers Harriman & Co's PRCT Position: Q3 2023 in Review

Brown Brothers Harriman & Co sold out of Procept Biorobotics (PRCT) in Q3 2023, closing a stake of 19,869 shares — an estimated $702K sold.

Brown Brothers Harriman & Co first reported a position in PRCT in Q2 2023 and held it in 1 quarter. The position peaked at $702K in Q2 2023. 127 funds tracked by Wall St. Rank hold PRCT as of Q3 2023.

  • Brown Brothers Harriman & Co reported no remaining Procept Biorobotics position as of Q3 2023 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 19,869 Procept Biorobotics shares in Q3 2023, an estimated $702K.
  • Brown Brothers Harriman & Co first reported a position in Procept Biorobotics in Q2 2023 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Procept Biorobotics position peaked at $702K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2023.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2023, filed 13 Nov 2023.